LSP BioVentures logo

LSP BioVentures

North America, Massachusetts, United States, Cambridge

Description

LSP BioVentures is a venture capital fund focused on opportunities in the life science arena.

Investor Profile

LSP BioVentures has made 29 investments, with 0 in the past 12 months and 48% as lead.

Stage Focus

  • Series A (31%)
  • Series B (28%)
  • Series C (21%)
  • Series Unknown (14%)
  • Series D (7%)

Country Focus

  • United States (34%)
  • Germany (24%)
  • United Kingdom (14%)
  • The Netherlands (7%)
  • Belgium (7%)
  • Switzerland (7%)
  • France (3%)
  • Denmark (3%)

Industry Focus

  • Biotechnology
  • Health Care
  • Therapeutics
  • Medical
  • Pharmaceutical
  • Life Science
  • Biopharma
  • Medical Device
  • Genetics
  • Manufacturing
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does LSP BioVentures frequently co-invest with?

Abingworth
Europe, England, United Kingdom, London
Co-Investments: 2
BioMedPartners
Europe, Basel-Stadt, Switzerland, Basel
Co-Investments: 3
Earlybird Venture Capital
Europe, Berlin, Germany, Berlin
Co-Investments: 2
Seventure Partners
Europe, Ile-de-France, France, Paris
Co-Investments: 2
Forbion Capital Partners
Europe, Noord-Holland, The Netherlands, Naarden
Co-Investments: 2
Atlas Venture
North America, Massachusetts, United States, Cambridge
Co-Investments: 2
SR One
North America, Massachusetts, United States, Cambridge
Co-Investments: 2
Sofinnova Partners
Europe, Ile-de-France, France, Paris
Co-Investments: 2
EMBL Ventures
Europe, Baden-Wurttemberg, Germany, Heidelberg
Co-Investments: 2
Pivotal bioVenture Partners
North America, California, United States, San Francisco
Co-Investments: 2

Which angels does LSP BioVentures often collaborate with?

PT
North America, California, United States, San Francisco
Shared Deals: 1
PF
North America, Massachusetts, United States, Boston
Shared Deals: 1

What are some of recent deals done by LSP BioVentures?

HotSpot Therapeutics

Boston, Massachusetts, United States

HotSpot Therapeutics is a developer of a therapy platform designed to discover medicines and provide proper treatment.

BiopharmaBiotechnologyHealth CareLife ScienceTherapeutics
Series CNov 29, 2021
Amount Raised: $100,000,000
Evommune

Palo Alto, California, United States

Evommune is a biotechnology company that develops therapeutics that halt progressive disease and address their symptoms.

BiotechnologyHealth CareLife Science
Series ASep 9, 2021
Amount Raised: $83,000,000
Muna Therapeutics

Copenhagen, Hovedstaden, Denmark

Muna Therapeutics discovers and develops therapies that slow or stop neurodegenerative diseases such as alzheimer’s and parkinson's.

BiopharmaBiotechnologyMedicalPharmaceutical
Series AJul 9, 2021
Amount Raised: $73,000,000
Innovative Molecules

Munich, Bayern, Germany

Innovative Molecules develops drugs designed to treat Herpes simplex-induced diseases.

BiotechnologyHealth CareMedical
Series AJun 9, 2021
Amount Raised: $24,357,213
New Amsterdam Pharma

Naarden, Noord-Holland, The Netherlands

New Amsterdam is a clinical-stage company focused on the research and development of transformative therapies for cardio-metabolic diseases.

BiotechnologyLife SciencePharmaceutical
Series AJan 14, 2021
Amount Raised: $194,412,819
Lumeon

London, England, United Kingdom

Lumeon is a digital health company providing management care solutions to the healthcare industry.

ComplianceHealth CareHospital
Series DAug 11, 2020
Amount Raised: $30,000,000
iSTAR Medical

Bel, Antwerpen, Belgium

iSTAR Medical focuses on developing innovative ophthalmic implants for patients suffering from eye diseases.

Health CareManufacturingMedical Device
Series CSep 5, 2019
Amount Raised: $44,137,980
Imcyse

Liège, Liege, Belgium

Developing disease specific immune therapies to treat severe, chronic auto-immune, inflammatory, allergic, infectious diseases and tumors.

BiotechnologyPharmaceuticalTherapeutics
Series BJun 18, 2019
Amount Raised: $31,354,386
Lumeon

London, England, United Kingdom

Lumeon is a digital health company providing management care solutions to the healthcare industry.

ComplianceHealth CareHospital
Series CDec 4, 2018
Amount Raised: $28,000,000
Aelin Therapeutics

Belgium, Wisconsin, United States

Aelin Therapeutics is a provider of a biotherapeutics platform technology called pept-ins that are intended to harnesses.

BiotechnologyHealth CareTherapeutics
Series ADec 11, 2017
Amount Raised: $31,795,042